SPL 3.06% 9.5¢ starpharma holdings limited

Ann: Trading Halt, page-131

  1. 15,478 Posts.
    lightbulb Created with Sketch. 5573
    I find it laughable that you think after all these years of the market being told by this very same person that Starpharma are in commercial discussions with several pharmaceutical companies / partners about our in house DEP trial data and still haven't been able to strike a licensing deal that suddenly one will surface in the 4 days we are in a TH ?


    Look what was said almost 2 years ago when the prostate cancer interim results were released in 2021 - "several" pharma companies / partners and yet not one of them in all that time have signed a deal .... ask yourself why ?


    upload_2023-7-31_8-50-57.png
    upload_2023-7-31_8-50-20.png



    AstraZeneca are a global giant with a market cap of circa $230 billion so if they were the slightest bit interested in Starpharma or saw something they liked about our DEP tech in the AZD0466 trials surely they would put in a bid for (say) < $1 billion while we have a market cap of circa $120 million ... again I would ask yourself why they haven't ?



    https://www.astrazeneca.com.au/

    AstraZeneca PLC (NASDAQ:AZN)

    Market Capitalization: $235.11 billion

    AstraZeneca PLC (NASDAQ:AZN) is a Cambridge, UK-based biopharmaceutical company that has made significant investments in the area of immunotherapy, with several promising developments in the field. The corporation has created several checkpoint inhibitors, including Imfinzi (durvalumab) and tremelimumab, which have been approved for the treatment of several different types of cancer. In Q1 2023, AstraZeneca PLC (NASDAQ:AZN) posted an EPS of $0.96, beating the analysts’ estimates by $0.14. Furthermore, the company recorded revenue of $10.88 billion, surpassing the analysts’ expectations by $319.8 million. AstraZeneca PLC (NASDAQ:AZN) offers an attractive forward dividend yield of 3.26% as of April 28.



    I think you will find no matter what 'spin' JF & Co. come up with in response to AstraZeneca's canning of all of the AZD0466 trials the market will be skeptical at best and can you honestly blame them after all that has been touted by this mob over the years that hasn't come to fruition ? Just look at the list @WBA posted ... great track record ?


    In answer to your question @peony-rose no ... the buy and sell orders are only purged if the company went into voluntary suspension, which would need to be requested by Starpharma on Tuesday as a follow on
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
-0.003(3.06%)
Mkt cap ! $39.17M
Open High Low Value Volume
10.0¢ 10.0¢ 9.5¢ $12.55K 130.3K

Buyers (Bids)

No. Vol. Price($)
4 586785 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 56840 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.